In-Depth Exploration of the Genomic Medicine France 2025
The Genomic Medicine France 2025 is a national initiative that aims to make France one of the leading countries in person-alized and precision medicine.It focuses on applying genomic medicine to rare diseases and cancer,and further incorporating genomic medicine into routine care,establishing a national framework for genomic medicine,and promoting scientific innovation and industrial development.The plan includes establishing sequencing platforms and data centers that can provide high-throughput sequencing services to hundreds of thousands of patients annually,implementing genomic clinical approaches to ensure the safety,quality,and efficiency of genomic testing and analysis,and creating an innovation,evaluation,and transformation consulting center to promote education and training,innovation and transformation of genomic medicine,policy support and social benefits.It also involves conducting researches in health economics to evaluate the cost effectiveness,budget impact,and social welfare of genomic medicine.The plan has achieved some important results in establishing sequencing platforms and data centers,granting genome testing and analysis licenses to hospitals,and releasing economic impact assessment reports.The plan also faces some challenges in dealing with COVID-19,legal restrictions on cloud computing services,and moral and social problems of genome data.The plan is expected to bring significant benefits to the French people in terms of health and quality of life,scientific knowledge and leadership,technological breakthroughs and innovative potential,economic growth and competitiveness.This article introduces the main objectives,measures,progress and challenges of the plan,as well as its potential impact on public health,scientific research,technological innovation,and economic development.
万方数据
